EUVIMEDEUVIMED entdecken
Crossref

HA/CD44–SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy

Ziguo Lin, Encheng Zhou, Da Zhang iD, Jianmei Ke, Yunhao Wang, Xinyu Zou, Lu Dong, Ruixuan Wang, Xiaolong Liu iD, Yanfeng Wang iD

ACS Nano · 17.02.2026 · 20 (6) · 4866-4890

DOI: 10.1021/acsnano.5c16933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 06.02.2026. Verfasst von Ziguo Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Manganese Compounds, Oxides, Reperfusion Injury, Acute Kidney Injury. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Manganese CompoundsOxidesReperfusion InjuryAcute Kidney InjuryMitochondriaHyaluronic AcidHyaluronan ReceptorsOligopeptidesAnimalsHumansMiceReactive Oxygen SpeciesCell LineMale

Stichwörter der Autor:innen

ischemia-reperfusion injurymitochondriananozymesreactive oxygen species scavengingtargeted drug delivery

Substanzen

Manganese CompoundsOxidesmanganese oxideHyaluronic AcidReactive Oxygen SpeciesHyaluronan ReceptorselamipretideOligopeptides

Autor:innen und Institutionen

  • Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
  • State Key Laboratory of Metabolism and Regulation in Complex Organisms, Wuhan 430072, China.
  • United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350007, China.
  • Department of Radiation Oncology, Affiliated Cancer Hospital of Zhengzhou University& Henan Cancer Hospital, Henan 450004, China.

ORCID-Profile: Da Zhang, Xiaolong Liu, Yanfeng Wang

Förderung

  • National Natural Science Foundation of China
  • Hubei Provincial Key Research and Development Program

Zitieren

APA

Lin, Z., Zhou, E., Zhang, D., Ke, J., Wang, Y., Zou, X., Dong, L., Wang, R., Liu, X., & Wang, Y. (2026). HA/CD44–SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy. ACS Nano, 20(6), 4866-4890. https://doi.org/10.1021/acsnano.5c16933

Vancouver

Lin Z, Zhou E, Zhang D, Ke J, Wang Y, Zou X, et al. HA/CD44–SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy. ACS Nano. 2026;20(6):4866-4890. doi:10.1021/acsnano.5c16933

BibTeX
@article{Lin2026,
  author = {Lin, Ziguo and Zhou, Encheng and Zhang, Da and Ke, Jianmei and Wang, Yunhao and Zou, Xinyu and Dong, Lu and Wang, Ruixuan and Liu, Xiaolong and Wang, Yanfeng},
  title = {HA/CD44–SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {4866--4890},
  doi = {10.1021/acsnano.5c16933}
}
Kostenlos starten →